Stocks
Novartis AGNVS
NYSEHealthcarePharmaceuticals$153.44-0.53%
A Switzerland-based pharmaceutical manufacturer focused on innovative prescription medicines across oncology, immunology, neuroscience, and cardiovascular diseases. The company generates revenue from a portfolio of patented drugs and late-stage pipeline assets, following the 2023 spin-off of its generics business, Sandoz. Investors closely monitor its clinical trial results, regulatory approvals, and patent expirations, which drive long-term revenue growth and margin stability.
Market Cap: $296.6B52W Range: $97.72 – $170.46
Congressional Interest in Novartis AG (NVS)
9 members of Congress have disclosed 27 trades in Novartis AG (NVS), a Healthcare company. The buy/sell breakdown shows 20 purchases versus 7 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
27
Unique Politicians
9
Buys
20
Sells
7
Who in Congress Is Trading NVS?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2007-08-05 | Randy Neugebauer | sell | $1K – $15K |
| 2007-08-02 | MICHAEL T. MCCAUL | buy | $8,686.38 |